Anzeige
Mehr »
Donnerstag, 09.07.2026 - Börsentäglich über 12.000 News
Paukenschlag! Diese Gratis-Aktien könnten jetzt Gold wert sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
180 Leser
Artikel bewerten:
(1)

Peritoneal Dialysis Market worth $14.16 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., July 9, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Peritoneal Dialysis Market is projected to grow from about USD 10.04 billion in 2026 to USD 14.16 billion by 2031, at a CAGR of 6.0%.

Browse through 280 market data tables and 60 figures spread across 300 pages and the in-depth TOC on the 'Peritoneal Dialysis Market - Global Forecast to 2031'

Peritoneal Dialysis Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 10.04 billion
  • 2031 Projected Market Size: USD 14.16 billion
  • CAGR (2026-2031): 6.0%

Peritoneal Dialysis Market Trends & Insights:

  • By disease indication, the end-stage renal disease segment dominated the market, with a share of 53.4% in 2025
  • By end user, the home care segment is expected to register the highest CAGR of 6.3%.
  • By offerings, the products segment dominated the market, with a share of 86.2% in 2025.
  • Asia Pacific is expected to register the highest CAGR of 7.6%.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=211750966

The increasing number of elderly individuals is probably the most significant contributing factor toward the rising demands for effective treatment of peritoneal dialysis at home for kidney disease. Chronic kidney disease is a major risk among the elderly, given that numerous physiological changes in renal function occur with age, and comorbidities such as diabetes and hypertension are also very common among the elderly. As the global population ages, the number of patients developing CKD is increasing. Consequently, a large population will need dialysis, and for the geriatric population, PD will be advantageous, as it can be done at home; this will improve quality of life, as such patients are able to remain independent and are less frequently admitted to the hospital. More importantly, existing evidence demonstrates that PD provides additional benefits for elderly patients compared with hemodialysis, including improved patient satisfaction and preservation of residual kidney function. However, home dialysis reduces the burden on healthcare facilities, making it the most critical solution to the healthcare needs of the elderly population. This is why there is a vulnerability of elderly patients towards kidney diseases, which has increased PD adoption as the preferred dialysis technique to treat them with the most effective method according to their needs.

The peritoneal solution bags segment accounts for the largest share of the peritoneal dialysis market.

The market share for peritoneal dialysis solution bags was the largest because these are one-time, single-use consumables that require continuous replenishment. In contrast to a dialysis machine, which is purchased only once, solution bags must be used every day, with demand consistently high. Consequently, a constant revenue stream will be created for manufacturers and suppliers. Patients on peritoneal dialysis also require a minimum number of bags per day, thereby increasing consumption. The reason why the solution bag segment remains on top in this market for peritoneal dialysis is that these bags are used and replaced at a high rate.

Request Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=211750966

The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment holds the largest market share of the peritoneal dialysis market.

Continuous Ambulatory Peritoneal Dialysis (CAPD) has been associated with good patient outcomes, notably the longer preservation of residual kidney function compared to hemodialysis. CAPD's gentle and continuous nature helps reduce stress on the kidneys, allowing patients to retain their ability at least for a long time. Moreover, the number of hospitalizations in CAPD patients is much smaller in comparison with hemodialysis patients, and this is mainly because of the home-based mode of treatment, as it reduces the threat of infections and complications possible at clinical levels. All these make CAPD patients healthier, with a higher quality of life and lower healthcare costs.

The Asia Pacific region is expected to exhibit the highest growth rate during the forecast period.

This is mainly driven by proactive healthcare reforms and policies initiated by governments in these nations for better access to dialysis treatments. Such measures concentrate on hospital infrastructures and making such basic dialysis facilities accessible to low-income groups. This includes increasing healthcare programs, then funding and subsidizing treatment costs, and raising public awareness of kidney disease and its management among governments as a strategy to address such significant disparities in access to healthcare. In that case, commitment towards improved healthcare delivery for underserved populations fosters a more inclusive environment to support peritoneal dialysis, which further drives the market growth in the region.

Inquire Before Buying @https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=211750966

Top Companies in Peritoneal Dialysis Market:

The Top Companies in Peritoneal Dialysis Market include Vantive (US), Fresenius Medical Care AG (Germany), Mozarc Medical (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), Mitra Industries Pvt Ltd (India), JMS Co., Ltd. (Japan), AMECATH (Egypt), Polymedicure (India), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), Romsons (India), SSEM Mthembu Medical (Pty) Ltd (South Africa), Renax Biomedical Technology Co., Ltd (China), and Advin Health Care (India).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Hemodialysis and Peritoneal Dialysis Market - Global Forecast to 2031

Catheters Market - Global Forecast to 2030

Incontinence Care Products Market - Global Forecast to 2030

Urology Devices Market - Global Forecast to 2030

Patient Monitoring Devices Market - Global Forecast to 2031

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/peritoneal-dialysis-market-worth-14-16-billion-by-2031--marketsandmarkets-302821676.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.